Antitumor Activity of Portulaca Oleracea L. Polysaccharide on HeLa Cells Through Inducing TLR4/NF-κB Signaling

Nutrition and Cancer

Volumn 69, Issue 1, 2017, Pages 131-139

  Zhao, Rui ^a   Zhang, Tao ^b   Ma, Baoling ^c   Li, Xing ^d  

^a HEILONGJIANG BAYI AGRICULTURAL UNIVERSITY   (China)

^b JIAMUSI UNIVERSITY   (China)

^c HEBEI NORMAL UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d Daqing People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; POLYSACCHARIDE; PORTULACA OLERACEA EXTRACT; PROTEIN BAX; PROTEIN BCL 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; VASCULOTROPIN; BAX PROTEIN, HUMAN; CHEMOKINE; CYTOKINE; LIPOPOLYSACCHARIDE; TLR4 PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG MECHANISM; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; CHEMISTRY; DRUG EFFECTS; METABOLISM; PORTULACA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL PROLIFERATION; CHEMOKINES; CYTOKINES; HELA CELLS; HUMANS; LIPOPOLYSACCHARIDES; NF-KAPPA B; POLYSACCHARIDES; PORTULACA; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 85001104711     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2017.1248294     Document Type: Article

References (36)

1. Paulos CM, Kaiser A, Wrzesinski C, Hinrichs CS, Cassard L, et al.:Toll-like receptors in tumor immunotherapy. Clin Cancer Res 13, 5280–5289, 2007.
2. Jouhi L, Renkonen S, Atula T, Mäkitie A, Haglund C, et al.:Different toll-like receptor expression patterns in progression toward cancer. Front Immunol 5, 638, 2014.
3. Toussi DN, and Massari P, :immune adjuvant effect of molecularly-defined toll-like receptor ligands. Vaccines (Basel) 2, 323–353, 2014.
4. Werner J, Decarlo CA, Escott N, Zehbe L, Ulanova M, et al.:Expression of integrins and toll-like receptors in cervical cancer:effect of infectious agents. Innate Immun 18, 55–69, 2012.
5. Yu L, Wang L, Li M, Zhong J, Wang Z, et al.:Expression of toll-like receptor 4 is downregulated during progression of cervical neoplasia. Cancer Immunol Immunother 59, 1021–1028, 2010.
6. Akira S, and Takeda K, :Toll-like receptor signalling. Nat Rev Immunol 4, 499–511, 2004.
7. Rossol M, Heine H, Meusch U, Quandt D, Klein C, et al.:LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol 31, 379–446, 2011.
8. Bai C, Yang X, Zou K, He H, Wang J, et al.:Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation. Naunyn Schmiedebergs Arch Pharmacol 389, 573–584, 2016.
9. Zhou YX, Xin HL, Rahman K, Wang SJ, Peng C, et al.:Portulaca oleracea L.:a review of phytochemistry and pharmacological effects. Biomed Res Int 925631, 2015.
10. Jiao ZZ, Yue S, Sun HX, Jin TY, Wang HN, et al.:Indoline amide glucosides from portulaca oleracea:isolation, structure, and DPPH radical scavenging activity. J Nat Prod 25, 2588–2597, 2015.
11. Rashed AN, Afifi FU, and Disi AM, :Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1. J Ethnopharmacol 88, 131–136, 2003.
12. 40 immobilized on polyamine functionalized polystyrene bead as catalyst. J Mol Catal A Chem 342, 74–82, 2011.
13. Zhao R, Cai YP, and Chen ZB, :Anti-uterine cervix cancer study of polysaccharide from portulace oleracea L. on aged tumor-bearing mice. Chinese J Gerontol 9, 4480–4482, 2013.
14. Zhao R, Gao X, Cai Y, Shao X, Jia G, et al.:Antitumor activity of Portulaca oleracea L. polysaccharides against cervical carcinoma in vitro and in vivo. Carbohyd Polym 96, 376–383, 2013.
15. Zhao Y, Wang C, Wu Z, Fang J, Zhu L, et al.:Synthesis and antitumor activity of novel aroylthiourea derivatives of podophyllotoxin. Invest New Drugs 30, 17–24, 2012.
16. Wang W, Nag SA, and Zhang R, :Targeting the NFκB signaling pathways for breast cancer prevention and therapy. Curr Med Chem 22, 264–289, 2015.
17. Shathish K, Sakthivel KM, and Guruvayoorappan C, :Protective Effect of Solanum muricatum on tumor metastasis by regulating inflammatory mediators and nuclear factor-kappa B subunits. J Environ Pathol Toxicol Oncol 34, 249–262, 2015.
18. Figueiredo RT, Bittencourt VC, Lopes LC, Sassaki G, and Barreto-Bergter E, :Toll-like receptors (TLR2 and TLR4) recognize polysaccharides of Pseudallescheria boydii cell wall. Carbohydr Res 356, 260–264, 2012.
19. Lin KI, Kao YY, Kuo HK, Yang WB, Chou A, et al.:Reishi polysaccharides induce immunoglobulin production through the TLR4/TLR2-mediated induction of transcription factor Blimp-1. J Biol Chem 281, 24111–24123, 2006.
20. Xu YY, Zhang YY, Ou YY, Lu XX, Pan LY, et al.:Houttuynia cordata Thunb. polysaccharides ameliorates lipopolysaccharide-induced acute lung injury in mice. J Ethnopharmacol 16, pii:S0378–8741(15)30032–5, 2015.
21. Lei W, Browning JD, Jr, Eichen PA, Lu CH, Mossine VV, et al.:Immuno-stimulatory activity of a polysaccharide-enriched fraction of Sutherlandia frutescens occurs by the toll-like receptor-4 signaling pathway. J Ethnopharmacol 172, 247–253, 2015.
22. Hsu HY, Hua KF, Lin CC, Lin CH, Hsu J, et al.:Extract of Reishi polysaccharides induces cytokine expression via TLR4-modulated protein kinase signaling pathways. J Immunol 173, 5989–5999, 2004.
23. Yin X, Chen L, Liu Y, Yang J, Ma C, et al.:Enhancement of the innate immune response of bladder epithelial cells by Astragalus polysaccharides through upregulation of TLR4 expression. Biochem Biophys Res Commun 397, 232–238, 2010.
24. Zhao R, Zhang T, Zhao H, and Cai Y, :Effects of Portulaca oleracea L. polysaccharides on phenotypic and functional maturation of murine bone marrow derived dendritic cells. Nutr Cancer 67, 987–993, 2015.
25. O'Neill LA, :When signaling pathways collide:positive and negative regulation of toll-like receptor signal transduction. Immunity 29, 12–20, 2008.
26. Lin WW, and Karin M, :A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117, 1175–1183, 2007.
27. Chai EZ, Siveen KS, Shanmugam MK, Arfuso F, Sethi G, et al.:Analysis of the intricate relationship between chronic inflammation and cancer. Biochem J 468, 1–15, 2015.
28. Balkwill F, and Coussens LM, :Cancer:an inflammatory link. Nature 431, 405–406, 2004.
29. Chow MT, and Luster AD, :Chemokines in cancer. Cancer Immunol Res 2, 1125–1131, 2014.
30. Vendramini-Costa DB, and Carvalho JE, :Molecular link mechanisms between inflammation and cancer. Curr Pharm Des 18, 3831–3852, 2012.
31. Thompson PA, Khatami M, and Baglole CJ, :Environmental immune disruptors, inflammation and cancer risk. Carcinogenesis 1, S232–S253, 2015.
32. Miao JW, Liu LJ, and Huang J, :Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma. Int J Oncol 45, 165–176, 2014.
33. Hefler LA, Grimm C, and Ackermann S, :An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer. Cancer Res 63, 3066–3068, 2003.
34. Kassim SK, El-Salahy EM, Fayed ST, Helal SA, Helal T, et al.:Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. Clin Biochem 37, 363–369, 2004.
35. Chen B, Hou ZH, Dong Z, and Li CD, :Crocetin downregulates the proinflammatory cytokines in methylcholanthrene-induced rodent tumor model and inhibits COX-2 expression in cervical cancer cells. Biomed Res Int 2015, 829513, 2015.
36. Balkwill F, :Tumour necrosis factor and cancer. Nat Rev Cancer 9, 361–371, 2009.